CASE REPORT
Fortuitous discovery of an NPM1 mutation in a myelodysplastic syndrome
Corentin Bassi,
Corentin Bassi
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Pierre Peterlin,
Pierre Peterlin
Hematology Clinic, Nantes University Hospital, Nantes, France
Search for more papers by this author Marie C. Béné,
Marie C. Béné
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Yannick Le Bris,
Yannick Le Bris
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Marion Eveillard,
Corresponding Author
Marion Eveillard
Hematology Biology, Nantes University Hospital, Nantes, France
Correspondence
Marion Eveillard, Hematology Biology, 9 quai Moncousu, 44093 Nantes Cedex1, France.
Email: [email protected]
Search for more papers by this author
Corentin Bassi,
Corentin Bassi
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Pierre Peterlin,
Pierre Peterlin
Hematology Clinic, Nantes University Hospital, Nantes, France
Search for more papers by this author Marie C. Béné,
Marie C. Béné
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Yannick Le Bris,
Yannick Le Bris
Hematology Biology, Nantes University Hospital, Nantes, France
Search for more papers by this author Marion Eveillard,
Corresponding Author
Marion Eveillard
Hematology Biology, Nantes University Hospital, Nantes, France
Correspondence
Marion Eveillard, Hematology Biology, 9 quai Moncousu, 44093 Nantes Cedex1, France.
Email: [email protected]
Search for more papers by this author
First published: 01 March 2021
No abstract is available for this article.
CONFLICT OF INTEREST
The authors declare no conflict of interests.
DATA AVAILABILITY STATEMENT
Not relevant.
REFERENCES
- 1Bains A, Luthra R, Medeiros LJ, Zuo Z. FLT3 and NPM1 Mutations in Myelodysplastic Syndromes: Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia. Am J Clin Pathol. 2011; 135: 62-69.
- 2Bain BJ, Heller M, Toma S, Pavlů J. The cytological features of NPM1 -mutated acute myeloid leukemia. Am J Hematol. 2015; 90: 560.
- 3Falini B, Brunetti L, Sportoletti P, Martelli MP. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020; 136: 1707-1721.